Seaport Therapeutics, Inc SPTX
—
21.52
0.40
1.89%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow SPTX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '24 | Dec '25 | |
|---|---|---|
Current Ratio |
27.82 | 17.46 |
Net Debt/EBITDA |
5.91 | 2.42 |
Debt/Assets |
0.11% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
— | 0.00 |
Operating CF/Net income |
0.63 | 1.04 |
Capex/Depreciation |
(0.53) | 0.18 |
Interest Coverage |
0.00 | 0.00 |
| 0.00% | 127.57% | |
| 0.00% | (26.52%) | |
ROIC |
0.00% | (324.62%) |
Return on Tangible Assets |
(15.67%) | (35.51%) |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% |
Free Cash Flow per Share |
(31.54) | (32.98) |
Cash per Share |
327.78 | 90.98 |
Shareholders Equity per Share |
318.64 | 98.06 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
318.64 | 98.06 |
Free Cash Flow |
(29.74) | (78.30) |
Working Capital |
299.00 | 210.45 |
Capital Expenditures |
(0.11) | (0.36) |
Net Current Asset Value |
294.85 | 207.00 |
| Other line items | ||
Quick Ratio |
27.72 | 16.90 |
Depreciation/Fixed assets |
0.89 | (4.91) |
Cash ROIC |
(4.90%) | (17.46%) |
Accounts Payable Turnover |
— | 0.00 |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(31.42) | (32.83) |
Capex per Share |
(0.12) | (0.15) |
Average Payables |
— | 3.37 |
Average Assets |
— | 282.39 |
Average Common Equity |
— | (58.70) |
Capex to Sales |
0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates